Rotavirus is the leading cause of severe diarrhoea in young children throughout the world, especially in developing countries. This can result in life-threatening dehydration for infants and young children.
Often, rotavirus vaccines are high in cost with barriers to distribution in developing countries due to stringent cold-chain storage requirements.
With the thermostable rotavirus vaccine in development, we will soon be able to safeguard children in all over the world from devastating rotavirus-associated outcomes.